Mitochondria as a Therapeutic Target in Heart Failure

详细信息    查看全文

• 作者：Marina Bayeva ; PhD^? ; Mihai Gheorghiade ; MD^&dagger ; ; Hossein Ardehali ; MD ; PhD^? ; ^{h-ardehali@northwestern.edu}
• 关键词：cardiomyocytes ; heart failure ; mitochondria
• 刊名：Journal of the American College of Cardiology
• 出版年：2013
• 出版时间：12 February, 2013
• 年：2013
• 卷：61
• 期：6
• 页码：599-610
• 全文大小：1692 K

文摘

Heart failure is a pressing public health problem with no curative treatment currently available. The existing therapies provide symptomatic relief, but are unable to reverse molecular changes that occur in cardiomyocytes. The mechanisms of heart failure are complex and multiple, but mitochondrial dysfunction appears to be a critical factor in the development of this disease. Thus, it is important to focus research efforts on targeting mitochondrial dysfunction in the failing heart to revive the myocardium and its contractile function. This review highlights the 3 promising areas for the development of heart failure therapies, including mitochondrial biogenesis, mitochondrial oxidative stress, and mitochondrial iron handling. Moreover, the translational potential of compounds targeting these pathways is discussed.